β-lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia colt, and Proteus mirabills isolates recovered in South Africa

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 6, 1998, Pages 1350-1354

  Pitout, J D D ^a,b   Thomson, K S ^a   Hanson, N D ^a   Ehrhardt, A F ^a   Moland, E S ^a   Sanders, C C ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; IMIPENEM; PIPERACILLIN; TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; ENZYME SYNTHESIS; ESCHERICHIA COLI; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; SPECTROPHOTOMETRY;

EID: 0031860676     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1350     Document Type: Article

References (36)

1. Ambler, R. P., A. F. W. Coulson, J. M. Frere, J. M. Ghuysen, B. Joris, M. Forsmann, R. C. Levesque, G. Tiraby, and S. G. Waley. 1991. A standard numbering scheme for the class A β-lactamases. Biochem. J. 276:269-270.
2. Barthélémy, M., J. Peduzzi, and R. Labia. 1988. Complete amino acid sequence of p453-plasmid-mediated PIT-2 β-lactamase (SHV-1). Biochem. J. 251:73-79.
3. Bauernfeind, A., Y. Chong, and S. Schweighart. 1989. Extended broad-spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17:316-321.
4. Bauernfeind, A., H. Grimm, and S. Schweighart. 1990. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18:294-298.
5. CMY-1 gene and its relationship with other β-lactamase genes. Antimicrob. Agents Chemother. 40:1926-1930.
6. Ben Hassen, A., G. Fournier, A. Kechrid, C. Fendri, S. Ben Redjeb, and A. Philippon. 1990. Résistance enzymatique au céfotaxime chez cinquante-six souches de Klebsiella spp., Escherichia coli et Salmonella spp. dans un hopital tunisien (1984-1988). Pathol. Biol. 38:464-469.
7. Billot-Klein, D., L. Gutmann, and E. Collatz. 1990. Nucleotide sequence of the SHV-5 β-lactamase gene of Klebsiella pneumoniae plasmid. Antimicrob. Agents Chemother. 34:2439-2441.
8. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
9. Coovadia, Y. M., A. P. Johnson, B. H. Bhana, C. R. Hutchinson, R. C. George, and I. E. Haferjee. 1992. Multiresistant Klebsiella pneumoniae in a neonatal nursery: the importance of maintenance of infection control policies and procedures in prevention of outbreaks. J. Hosp. Infect. 22:197-205.
10. Derby, P., and J. Berens. 1997. Letter. South Afr. Med. J. 87:80.
11. DuBois, S. K., M. S. Marriott, and S. G. B. Amyes. 1995. TEM- and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure and function. J. Antimicrob. Chemother. 35:7-22.
12. Hibbert-Rodgers, L. C., J. Heritage, N. Todd, and P. M. Hawkey. 1994. Convergent evolution of TEM-26, a β-lactamase with extended-spectrum activity. J. Antimicrob. Chemother. 33:707-720.
13. Huletsky, A., F. Coutre, and R. C. Levesque. 1990. Nucleotide sequence and phylogeny of SHV-2 β-lactamase. Antimicrob. Agents Chemother. 34:1725-1732.
14. Jacoby, G. A., and A. A. Medeiros. 1991. More extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 35:1697-1704.
15. Jarlier, V., M.-H. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterohacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
16. Karas, J. A., D. G. Pillay, D. Muckart, and A. W. Sturm. 1996. Letter. J. Antimicrob. Chemother. 37:203-204.
17. Mariotte, S., P. Nordmann, and M. H. Nicolas. 1994. Extended-spectrum β-lactamase in Proteus mirabilis. J. Antimicrob. Chemother. 33:925-935.
18. Matthew, M. A., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
19. Mercier, J., and R. C. Levesque. 1990. Cloning of SHV-2, OHIO-1, and OXA-6 β-lactamases and cloning and sequencing of SHV-1 β-lactamase. Antimicrob. Agents Chemother. 34:1577-1583.
20. National Committee for Clinical Laboratory Standards. 1994. Methods for dilution antimicrobial susceptibility for bacteria that grow aerobically, M7-T2, 4th ed. National Committee for Clinical Laboratory Standards, Villanova, Pa.
21. National Committee for Clinical Laboratory Standards. 1994. Performance standards for antimicrobial disk susceptibility tests, M2-T4, 4th ed. National Committee for Clinical Laboratory Standards, Villanova, Pa.
22. Naumovski, L., J. P. Quinn, D. Miyashiro, M. Patel, K. Bush, S. B. Singer, D. Graves, T. Palzkill, and A. M. Arvin. 1992. Outbreak of ceftazidime resistance due to extended-spectrum β-lactamases in isolates from cancer patients. Antimicrob. Agents Chemother. 36:1991-1996.
23. O'Callaghan, C. H., P. W. Muggleton, S. M. Kirby, and D. M. Ryan. 1967. Inhibition of β-lactamase decomposition of cephaloridine and cephalothin by other cephalosporins. Antimicrob. Agents Chemother. 11:337-343.
24. Palzkill, T., K. S. Thomson, C. C. Sanders, E. S. Moland, W. Huang, and T. W. Milligan. 1995. New variant of TEM-10 β-lactamase gene produced by a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 39: 1199-1200.
25. Papanicolaou, G. A., A. A. Medeiros, and G. A. Jacoby. 1990. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34:2200-2209.
26. Payne, D. J., N. Woodford, and S. G. Amyes. 1992. Characterization of the plasmid mediated beta-lactamase BIL-1. J. Antimicrob. Chemother. 30:119-127.
27. Philippon, A., R. Labia, and G. A. Jacoby. 1989. Extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 33:1131-1136.
28. Pitout, J. D. D., E. S. Moland, C. C. Sanders, K. S. Thomson, and S. R. Fitzsimmons. 1997. β-Lactamases and detection of β-lactam resistance in Enterobacter spp. Antimicrob. Agents Chemother. 41:35-39.
29. Richard, C., A. Philippon, S. M'Boup, and J. F. Vieu. 1989. Epidemiologie des infections pediatriques a Klebsiella dans deux hopitaux de Dakar. Production de β-lactamases a spectre elargi (1987-1988). Med. Mal. Infect. 19: 753-759.
30. Sanders, C. C., and W. E. Sanders, Jr. 1992. β-Lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin. Infect. Dis. 15:824-839.
31. Sanders, C. C., W. E. Sanders, Jr., and E. S. Moland. 1986. Characterization of β-lactamases in situ on polyacrylamide gels. Antimicrob. Agents Chemother. 30:951-952.
32. Sirot, D. 1995. Extended-spectrum plasmid-mediated β-lactamases. J. Antimicrob. Chemother. 36(Suppl. A):19-34.
33. Soilleux, M. J., A. M. Morand, G. J. Arlet, M. R. Scavizzi, and R. Labia. 1996. Survey of Klebsiella pneumoniae producing extended-spectrum β-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France. Antimicrob. Agents Chemother. 40:1027-1029.
34. Sutcliffe, J. G. 1978. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 75:3737-3741.
35. Thomson, K. S., A. M. Prevan, and C. C. Sanders. 1996. Novel plasmid-mediated β-lactamases in Enterobacteriaceae: emerging problems for new β-lactam antibiotics. Curr. Clin. Top. Infect. Dis. 16:151-163.
36. Watanabe, Y., T. Yokota, Y. Higashi, Y. Wakai, and Y. Mine. 1991. In-vitro and in-vivo transferable β-lactam resistance due to new plasmid-mediated oxyiminocephalosporinase from a clinical isolate of Proteus mirabilis. Microbiol. Immunol. 35:87-97.